These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5045427)

  • 1. Pharmacologic properties of a new oral contrast medium for cholecystography.
    Rosati G; De Micheli P; Schiantarelli P
    Acta Radiol Diagn (Stockh); 1972 May; 12(3):335-46. PubMed ID: 5045427
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the toxicology of a new oral contrast medium for cholecystography.
    Rosati G; De Micheli P; Schiantarelli P
    Acta Radiol Diagn (Stockh); 1972 Nov; 12(6):882-90. PubMed ID: 4651757
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology and physiology of the biliary radiographic contrast materials.
    Berk RN; Loeb PM
    Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicologic and pharmacologic properties of iocetamic acid, a new oral cholecystographic agent.
    Janbroers JM; Sanders JC; Til HP; Feron VJ; De Groot AP
    Toxicol Appl Pharmacol; 1969 Mar; 14(2):232-41. PubMed ID: 5772846
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopaque contrast media. XXXVIII - Iopronic acid, a new contrast medium for oral cholecystography: toxicologic investigation.
    Tirone P; Rosati G
    Farmaco Prat; 1976 Sep; 31(9):437-46. PubMed ID: 1010018
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic excretion of cholecystopaques introduced into the canine jejunum.
    Menuck L; Amberg JR; Bates M
    Invest Radiol; 1977; 12(1):106-8. PubMed ID: 138663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of oral cholecystopaque media and iodipamide.
    Goergen T; Goldberger LE; Berk RN
    Radiology; 1974 Jun; 111(3):543-8. PubMed ID: 4828985
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiopaque contrast media. XXVII. Pharmacologic properties of iodoxamic acid, a new contrast medium for intravenous cholegraphy.
    Rosati G; Schiantarelli P; Tirone P
    Farmaco Sci; 1973 Dec; 28(12):996-1010. PubMed ID: 4765762
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors in the intestinal absorption of oral cholecystopaques.
    Amberg JR; Thompson WM; Golberger L; Williamson S; Alexander R; Bates M
    Invest Radiol; 1980; 15(6 Suppl):S136-41. PubMed ID: 7203915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and preliminary pharmacologic evaluation of a zwitterionic oral cholecystographic agent.
    Sovak M; Barnhart JL; Ranganathan R; Schulze PE; Siefert HM; Speck U
    Invest Radiol; 1981; 16(6):513-6. PubMed ID: 7319759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AN INVESTIGATION ON OPAQUE MEDIA FOR CHOLECYSTOGRAPHY.
    O'SHEA JJ
    Radiography; 1964 May; 30():135-6. PubMed ID: 14145069
    [No Abstract]   [Full Text] [Related]  

  • 16. Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs.
    Hunter TB; Fon GT; Berk RN; Capp MP
    Gastrointest Radiol; 1981; 6(4):349-52. PubMed ID: 7308718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual contrast medium in the intestines and side effects during cholecystography. A comparison between some contrast media in current use and a new medium.
    Eriksson S; Saltzman GF
    Acta Radiol Diagn (Stockh); 1970 Jan; 10(1):69-75. PubMed ID: 5447107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost].
    Quasdorf M; Becker C; Quasdorf G; Becker HW
    Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent triiodinated contrast media for oral cholecystocholangiography].
    Sviridov NK; Popova ZP; Varfolomeeva VN
    Med Radiol (Mosk); 1985 Feb; 30(2):58-60. PubMed ID: 3155821
    [No Abstract]   [Full Text] [Related]  

  • 20. ACUTE RENAL FAILURE FOLLOWING ORAL CHOLECYSTOGRAPHY.
    TEPLICK JG; MYERSON RM; SANEN FJ
    Acta Radiol Diagn (Stockh); 1965 Jul; 3():353-69. PubMed ID: 14328214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.